Iron Chelation Therapy in Sickle Cell/Beta Thalassemia Syndrome, a 2 years’ Extension Study

  • Hayder Al-Momen
Published
2019-04-18
How to Cite
Al-Momen, H. (2019). Iron Chelation Therapy in Sickle Cell/Beta Thalassemia Syndrome, a 2 years’ Extension Study. AL-Kindy College Medical Journal, 13(1), 76-81. https://doi.org/10.47723/kcmj.v13i1.130